Skip to main content

WPI 3355 Pill - pink capsule/oblong, 17mm

Pill with imprint WPI 3355 is Pink, Capsule/Oblong and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc.

Nateglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3355

Nateglinide 120 mg WPI 3355
Nateglinide 120 mg WPI 3355

Nateglinide

Imprint
WPI 3355
Strength
120 mg
Color
Pink
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories Inc.
National Drug Code (NDC)
00591-3355
Inactive Ingredients
silicon dioxide, fumaric acid, hypromellose 2910 (3 mPa.s), lactose monohydrate, magnesium stearate, polysorbate 80, sodium starch glycolate type A potato, corn starch, titanium dioxide, hypromellose 2910 (6 mPa.s), FD&C Red No. 40, ferric oxide red, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.